Wegovy
Branded semaglutide, FDA-approved for chronic weight management.
- Category
- GLP-1
- Form
- Weekly injection pen
Treatment is only supplied where clinically appropriate and approved by a licensed doctor.
What is Wegovy?
Wegovy is Novo Nordisk's branded semaglutide, dosed for weight management. It regulates appetite and food intake through GLP-1 receptor activity.
Clinical benefits
- FDA-approved for chronic weight management
- Consistent branded formulation
- Weekly injection pen
- Backed by STEP trial data
From assessment to delivery
Every prescription starts with a doctor. Here's the flow from your first form to ongoing care.
1. Assessment
Complete a clinical intake — 10 minutes.
2. Doctor review
A licensed doctor reviews your case and eligibility.
3. Delivered
If prescribed, treatment is delivered discreetly to you.
4. Ongoing care
Titration, follow-ups and adjustments as needed.
Others in Weight Loss & Metabolic Health
Compounded Tirzepatide
Dual-action GLP-1 / GIP receptor agonist for advanced metabolic support.
Learn moreCompounded Semaglutide
GLP-1 receptor agonist supporting appetite regulation and weight loss.
Learn moreMounjaro
Branded tirzepatide by Eli Lilly for glycemic and weight control.
Learn moreOzempic
Branded semaglutide indicated for type 2 diabetes.
Learn moreExplore the rest of Castill Health
Hair Restoration & Hormonal Health
Personalised regrowth protocols tailored to your biology.
View programMen's Health & Sexual Performance
Confidence, blood flow and performance — clinically guided.
View programLongevity & Healthy Aging
Cellular repair, recovery and long-term vitality.
View programPerformance & Recovery
Body composition, resilience and physical performance.
View programCommon questions about Wegovy
Still unsure? Start the assessment and a licensed doctor will address your specific case.
Get StartedStart your assessment
10 minutes. Doctor-reviewed. Treatment only if clinically appropriate.